In our study, we comprehensively evaluated the molecular characterization in UTUC and developed a Ki67/Her2/E-cadherin-based IHCscore to predict the recurrence-free survival of patients with UTUC receiving KSS. The gene discussed is CDH1; the disease is renal pelvis/ureter urothelial carcinoma.